It seems that the sensitivity of [18F]FDG-PET/CT scan for the detection of MTC recurrence, in patients with elevated calcitonin levels and negative or equivocal conventional imaging findings, is determined by the level of serum calcitonin. The gene discussed is CALCA; the disease is medullary thyroid gland carcinoma.